Cytokine regulation of liver injury and repair

Immunological Reviews

Volumn 174, Issue , 2000, Pages 160-171

  Diehl, Anna Mae ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE SYNTHASE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCOUPLING PROTEIN 2;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CONTROLLED STUDY; CYTOKINE RELEASE; DEFENSE MECHANISM; FATTY LIVER; GENE EXPRESSION; LIVER CELL; LIVER INJURY; LIVER MITOCHONDRION; LIVER NECROSIS; LIVER REGENERATION; LIVER TOXICITY; MEMBRANE DEPOLARIZATION; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; OBESITY; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROTEIN EXPRESSION; REVIEW; SENSITIZATION; STRESS;

ADAPTATION, PHYSIOLOGICAL; ALCOHOLISM; ANIMALS; APOPTOSIS; CYTOKINES; FATTY LIVER; GENE EXPRESSION REGULATION; GENES, BCL-2; GRAM-POSITIVE BACTERIAL INFECTIONS; HEPATECTOMY; HUMANS; LIPOPOLYSACCHARIDES; LIVER; LIVER DISEASES; LIVER REGENERATION; OBESITY; PROPIONIBACTERIUM ACNES; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034127757     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0528.2002.017411.x     Document Type: Review

References (90)

1. 1. Trautwein C, Rakemann T, Niehof M, Rose-John S, Manns MP. Acute-phase response factor, increased binding, and target gene transcription during liver regeneration. Gastroenterology 1996;110:1854-1862.
2. 2. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990;192:245-261.
3. 3. Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 1993;9:317-343.
4. 4. Feingold KR, Soued M, Grunfeld C. Tumor necrosis factor stimulates DNA synthesis in the liver of intact rats. Biochem Biophys Res Commun 1988;153:576-582.
5. 5. Beyer HS, Stanley M, Theologides A. Tumor necrosis factor-α increases hepatic DNA and RNA and hepatocyte mitosis. Biochem Int 1990;22:405-410.
6. 6. Diehl AM, Rai R. Regulation of signal transduction during liver regeneration. FASEB J 1996;10:215-227.
7. 7. Akerman P, Cote P, Yang SQ, et al. Antibodies to tumor necrosis factor α inhibit liver regeneration after partial hepatectomy. Am J Physiol 1992;263:G579-G585.
8. 8. Yamada Y, Kirillova I, Peschon JJ. Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA 1997;94:1441-1446.
9. 9. Hishinuma I, et al. Tumor necrosis factor-α in galactosamine-induced hepatitis. Hepatology 1990;12:1187-1191.
10. 10. Vassalli P. The pathophysiology of tumor necrosis factor. Annu Rev Immunol 1992;10:411-452.
11. + T cells but induces type 1 T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. J Immunol 1997;159:97-106.
12. 12. Fernandez-Checa JC, et al. GSH transport in mitochondria: defense against TNF-induced oxidative stress and alcohol-induced defect. Am J Physiol 1997;273:G7-G17.
13. 13. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 1997;94:2557-2562.
14. 14. Faggioni R, Fantuzzi G, Gabay C, et al. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 1999;276:R136-R142.
15. 15. Tanaka Y, et al. A pivotal role of IL-12 in Th1-dependent mouse liver injury. Int Immunol 1996;8:569-576.
16. int liver lymphocytes: influence of thymus, β2-microglobulin and NK1.1 expression. Int Immunol 1995;7:1729-1739.
17. 17. Okamura H, Kashiwamura S, Tsutsui H, Yoshimoto T, Nakanishi K. Regulation of interferon-γ production by IL-12 and IL-18. Curr Opin Immunol 1998;10:259-264.
18. 18. Sako Y, et al. IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock. Int Immunol 1999;11:471-480.
19. 19. Car BD, et al. Interferon-γ receptor deficient mice are resistant to endotoxic shock. J Exp Med 1994;179:1437-1444.
20. 20. Car BD, Eng VM, Schnyder B, et al. Role of interferon-γ in interleukin 12-induced pathology in mice. Am J Pathol 1995;147:1693-1707.
21. 21. Dinarello CA. IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999;103:11-24.
22. 22. Dao T, Mehal WZ, Crispe IN. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J Immunol 1998;161:2217-2222.
23. 23. Ohtsuki T, Micallef MJ, Kohono K, Tanimoto T, Ikeda M, Kurimoto M. Interleukin 18 enhances Fas ligand expression and induces apoptosis in Fas-expressing human myelomonocytic KG-1 cells. Anticancer Res 1997;17:3253-3258.
24. 24. Samazasinghe D, Tasman-Jones C. The clinical associations with hepatic steatosis: a retrospective study. N Z Med J 1992;105:57-58.
25. 25. Chavin K, et al. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem 1999;274:5692-5700.
26. 26. Nanji AA, Khettry U, Sadrzadeh SMH, Tamanaka T. Severity of liver injury in experimental alcoholic liver disease. Am J Pathol 1993;142:367-73.
27. 27. D'Alessandro AM, et al. The predictive value of donor liver biopsy on the development of primary nonfunction after orthotopic liver transplantation. Transpl Proc 1991;23:1536-1537.
28. 28. Loffreda S, et al. Leptin regulates proinflammatory immune responses. FASEB J 1998;12:57-65.
29. 29. Lee F-Y, et al. Phenotypic abnormalities in macrophages from leptin deficient, obese mice. Am J Physiol Cell Physiol 1999;276:C386-C394.
30. 30. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251-276.
31. +NKT cells. J Immunol 1999;162:5094-5098.
32. 32. Marvin MR, Southall JC, Trokhan S, De Rosa C, Chabot J. Liver metastases are enhanced in homozygous deletionally mutant ICAM-1 or LFA-1 mice. J Surg Res 1998;80:143-148.
33. 33. Dong ZM, Gutierrez-Ramos JC, Coxon A, Mayadas TN, Wagner DD. A new class of obesity genes encodes leukocyte adhesion receptors. Proc Natl Acad Sci USA 1997;94:7526-7530.
34. 34. Rashid A, et al. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology (In press).
35. 35. Petersen P. Ultrastructure of periportal and centrilobular hepatocytes in human fatty liver of various etiologies. Acta Pathol Microbiol Scand 1977;85:421-427.
36. 36. Katyare S, Howland JL. Enhanced oxidative metabolism in liver mitochondria form genetically obese mice. Arch Biochem Biophys 1978;188:15-20.
37. 37. Boss O, Muzzin P, Giacobino JP. The uncoupling proteins, a review. Eur J Endocrinol 1998;139:1-9.
38. 38. Diehl AM, et al. Tumor necrosis factor-α induces c-jun during the regenerative response to liver injury. Am J Physiol 1994;267:G552-G561.
39. 39. Cressman DE, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379-1383.
40. 40. Rai RM, Loffreda S, Karp CL, Yang SQ, Lin HZ, Diehl AM. Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained over-expression of tumor necrosis factor-α mRNA in the regenerating rat liver. Hepatology 1997;25:889-895.
41. 41. Magnusson C, Vaux DL. Signaling by CD95 and TNF receptors: not only life and death. Immunol Cell Biol 1999;77:41-46.
42. 42. Baker SJ, Reddy EP. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 1996;12:1-9.
43. 43. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998;94:491-501.
44. 44. Gross A, et al. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 1999;274:1156-1163.
45. 45. Schulze-Osthoff K, Beyaert R, Vandevoorde V, Haegeman G, Fliers W. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J 1993;12:3095-3104.
46. 46. Higuchi M, Aggarwal BB, Yeh ET. Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function. J Clin Invest 1997;99:1751-1758.
47. 47. Gudz TI, Tserng KY, Hoppel CL. Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide. J Biol Chem 1997;272:14154-14158.
48. 48. Schulze-Osthoff K, Ferrari D, Riehemann K, Wesselborg S. Regulation of NF-κB activation by MAP kinase cascades. Immunobiology 1997;198:35-49.
49. 49. Sonenshein GE. Rel/NF-κB transcription factors and the control of apoptosis. Semin Cancer Biol 1997;8:113-119.
50. 50. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin ASJ. NF-κB antiapoptosis: induction of TFAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 1998;11:1680-1683.
51. 51. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 1998;8:297-303.
52. 52. Tamatani M, Che YH, Matsuzaki H, et al. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFκB activation in primary hippocampal neurons. J Biol Chem 1999;274:8531-8538.
53. 53. Zong WX, Edelstein LC, Chen C, Bash J, Gelinas C. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes Dev 1999;13:382-387.
54. 54. Pandey P, et al. Bcl-xL blocks activation of related adhesion focal tyrosine kinase/proline-rich tyrosine kinase 2 and stress-activated protein kinase/c-Jun N-terminal protein kinase in the cellular response to methylmethane sulfonate. J Biol Chem 1999;274:8618-86123.
55. 55. Westwick JK, Weitzel C, Minden A, Karin M, Brenner DA. Tumor necrosis factor α stimulates AP-1 activity through prolonged activation of the c-jun kinase. J Biol Chem 1994;269:26396-26401.
56. 56. Bost F, McKay R, Bost M, Potapova O, Dean NM, Mercola D. The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells. Mol Cell Biol 1999;19:1938-1949.
57. 57. D'Sa-Eipper C, Subramanian T, Chinnadurai G. Bfl-1, a Bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity. Cancer Res 1996;56:3879-3882.
58. 58. D'Sa-Eipper C, Chinnadurai G. Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities. Oncogene 1998;16:3105-3114.
59. 59. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem 1992;267:5317-5323.
60. 60. Li Y, Zhu H, Kuppusamy P, Roubaud V, Zweier JL, Trush MA. Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting Superoxide anion radical production by enzymatic and cellular systems. J Biol Chem 1998;273:2015-2023.
61. 61. Lee FYJ, et al. Tumor necrosis factor α increases mitochondrial oxidant production and induces expression of uncoupling protein-2 expression in the regenerating mouse liver. Hepatology (In press).
62. 62. Cressman DE, Greenbaum LE, Haber BA, Taub R. Rapid activation of PHF/NF κB in hepatocytes, a primary response in the regenerating liver. J Biol Chem 1994;269:30429-30435.
63. 63. Hilberg F, Aguzzi A, Howells N, Wagner EF. c-jun is essential for normal mouse development and hepatogenesis. Nature 1993;365:179-181.
64. 64. Hibi M, Lin A, Smeal T, Minden A, Karin M. Identification of an oncoprotein-and HIV-responsive protein kinase that binds and potentiates the c-jun activation domain. Genes Dev 1993;7:2135-2148.
65. 65. Derijard B, et al. A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994;76:1025-1038.
66. 66. Ganiatsas S, et al. SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis. Proc Natl Acad Sci USA 1998;95:6881-6886.
67. 67. Yan M, et al. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature 1994;372:798-800.
68. 68. Michalopoulos G. Liver regeneration: molecular mechanisms of growth control. FASEB J 1990;4:176-187.
69. 69. Tzung SP, Fausto N, Hockenberry DM. Expression of Bcl-2 family during liver regeneration and identification of Bcl-x as a delayed early response gene. Am J Pathol 1997;150:1985-1995.
70. 70. Kren BT, Trembley JH, Krarewski S, Behrens TW, Reed JC, Steer CJ. Modulation of appoptosis-associated genes bcl-2, bcl-x, and box during liver regeneration. Cell Growth Differ 1996;7:1633-1642.
71. 71. Cortez-Pinto H, Lin HZ, Yang SQ, Odwin da Costa S, Diehl AM. Lipids up-regulate uncoupling protein-2 expression in hepatocytes. Gastroenterology (In press).
72. 72. Rai RM, et al. Impaired liver regeneration in inducible nitric oxide synthase-deficient mice. Proc Natl Acad Sci USA 1998;95:13829-13834.
73. 73. Minnard EA, Shou J, Naama H, Cech A, Gallagher H, Daly JM. Inhibition of nitric oxide synthase is detrimental during endotoxemia. Arch Surg 1994;129:142-148.
74. 74. Harbrecht B, Stadler J, Demetris A, Simmons R, Billiar T. Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia. Am J Physiol 1994;266:G1004-G1010.
75. 75. Laubach VE, Shesely EG, Smithies O, Sherman PA. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 1995;92:10688-10692.
76. 76. Duval DL, Miller DR, Collier J, Billings RE. Characterization of hepatic nitric oxide synthase: identification as the cytokine-inducible form primarily regulated by oxidants. Mol Pharmacol 1996;50:277-284.
77. 77. Horie Y, Wolf R, Granger DN. Role of nitric oxide in gut ischemia-reperfusion-induced hepatic microvascular dysfunction. Am J Physiol 1997;273:G1007-G1013.
78. 78. Kim YM, Talanian RV, Billiar TR. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 1997;272:31138-31148.
79. 79. Li J, Billiar TR, Talanian RV, Kim YM. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun 1997;240:419-424.
80. 80. McClain CJ, Hill DB, Schmidt J, Diehl AM. Cytokines and alcoholic liver disease. Semin Liv Dis 1993;13:170-182.
81. 81. Carter EA, Wands JR. Ethanol inhibits hormone stimulated hepatocyte DNA synthesis. Biochem Biophys Res Commun 1985;128:767-774.
82. 82. Wands JR, Carter EA, Bucher NLR, Isselbacher KJ. Inhibition of hepatic regeneration in rats by acute and chronic ethanol intoxication. Gastroenterology 1979;77:528-531.
83. 83. Orrego H, Crossley IR, Saldiva V, Medline A, Varghese G, Israel Y. Long-term ethanol administration and short-and long-term liver regeneration after partial hepatectomy. J Lab Clin Med 1981;97:402-413.
84. 84. Dugay L, Couter D, Hetu C, Joly JG. Inhibition of liver regeneration by chronic alcohol administration. Gut 1982;23:8-13.
85. 85. Diehl AM, Chacon MA, Wagner P. The effect of chronic ethanol feeding on ornithine decarboxylase activity and liver regeneration. Hepatology 1988;8:237-242.
86. 86. Yang SQ, Lin HZ, Yin M, Albrecht JH, Diehl AM. Effects of chronic ethanol consumption on cytokine regulation of liver regeneration. Am J Physiol 1998;275:G696-G704.
87. 87. Lin HZ, Yang SQ, Zeldin G, Diehl AM. Chronic ethanol consumption induces the production of tumor necrosis factor-α and related cytokines in liver and adipose tissue. Alcohol Clin Exp Res 1998;22(Suppl):231S-247S.
88. 88. Zeldin G, Rai R, Yang SQ, Lin HZ, Yin M, Diehl AM. Effects of alcohol on cytokine-inducible transcription factors. Alcohol Clin Exp Res 1996;20:1639-1645.
89. 89. Diehl AM, Yang SQ, Wolfgang D, Wand G. Differential expression of guanine nucleotide-binding proteins enhances cAMP synthesis in regenerating rat liver. J Clin Invest 1992;89:1706-1712.
90. 90. Westwick JK, et al. Differential regulation of hepatocyte DNA synthesis by cAMP in vitro and in vivo. Am J Physiol 1996;271:G780-G790.